Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
26,178
Total Claims
$2.2M
Drug Cost
714
Beneficiaries
$3,049
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+116%
Cost per patient vs peers
$3,049 vs $1,411 avg
+41%
Brand preference vs peers
15.0% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
23
Opioid Claims
$141
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,887 claims · $1.6M
Generic: 22,041 claims · $526K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 913 | $288K |
| Dulaglutide | 171 | $157K |
| Pimavanserin Tartrate | 41 | $97K |
| Paliperidone Palmitate | 43 | $88K |
| Empagliflozin | 142 | $69K |
| Bictegrav/Emtricit/Tenofov Ala | 12 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 119 | $43K |
| Sitagliptin Phosphate | 98 | $36K |
| Dapagliflozin Propanediol | 37 | $36K |
| Linagliptin | 111 | $35K |
| Insulin Degludec | 48 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 83 | $29K |
| Budesonide/Formoterol Fumarate | 62 | $28K |
| Insulin Aspart | 63 | $28K |
| Linaclotide | 46 | $26K |
Prescribing Profile
Patient Profile
72
Avg Age
53%
Female
2.84
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data